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Abstract
Purpose: Metabolic parameters are increasingly being used to characterize tumors. Motion artifacts due to patient
respiration introduce uncertainties in quantification of metabolic parameters during positron emission tomography
(PET) image acquisition. The present study investigates the impact of amplitude-based optimal respiratory gating
(ORG) on quantification of PET-derived image features in patients with pancreatic ductal adenocarcinoma (PDAC), in
correlation with overall survival (OS).
Methods: Sixty-nine patients with histologically proven primary PDAC underwent 2′-deoxy-2′-[18F]fluoroglucose
([18F]FDG) PET/CT imaging during diagnostic work-up. Standard image acquisition and reconstruction was
performed in accordance with the EANM guidelines and ORG images were reconstructed with a duty cycle of 35%.
PET-derived image features, including standard parameters, first- and second-order texture features, were calculated
from the standard and corresponding ORG images, and correlation with OS was assessed.
Results: ORG significantly impacts the quantification of nearly all features; values of single-voxel parameters (e.g.,
SUVmax) showed a wider range, volume-based parameters (e.g., SUVmean) were reduced, and texture features were
significantly changed. After correction for motion artifacts using ORG, some features that describe intra-tumoral
heterogeneity were more strongly correlated to OS.
Conclusions: Correction for respiratory motion artifacts using ORG impacts the quantification of metabolic
parameters in PDAC lesions. The correlation of metabolic parameters with OS was significantly affected, in particular
parameters that describe intra-tumor heterogeneity. Therefore, interpretation of single-voxel or average metabolic
parameters in relation to clinical outcome should be done cautiously. Furthermore, ORG is a valuable tool to
improve quantification of intra-tumoral heterogeneity in PDAC.
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Introduction
Pancreatic malignancies have a dismal prognosis. The
primary treatment for patients with a resectable tumor
is surgery, resulting in a 23% 5-year survival. In patients
with unresectable tumor or metastatic disease, 5-year
survival decreases to 6% [1]. Although FOLFIRINOX [2]
and nab-paclitaxel [3] have shown slightly better out-
come as compared to gemcitabine-containing regimen,
no effective systemic treatment options are available for
irresectable or distant metastatic disease [4].
2′-deoxy-2′-[18F]fluoroglucose ([18F]FDG) PET/CT
scanning is not standard in the diagnostic work-up for
pancreatic cancer. In most institutes, this modality is
mainly used to rule out distant metastases prior to
planned surgery. Recent literature suggests that meta-
bolic features of the primary tumor might associate with
overall survival (OS) in patients with pancreatic ductal
adenocarcinoma (PDAC). For many other malignancies,
e.g., endometrial cancer [5], non-small cell lung carcin-
oma [6, 7], sarcomas [8] and bone metastatic breast can-
cer [9], higher [18F]FDG uptake in the primary tumor
tends to associate with worse OS. For PDAC, recent
studies use a manifold of different metabolic parameters
to correlate to OS, yielding conflicting results.
Some studies showed a significant association between
standardized uptake value (SUV), mostly SUVmax, and
OS [10, 11], but results are equivocal [12, 13]. Measures
for intratumoral heterogeneity may provide alternative
biomarkers with prognostic impact [14, 15].
Several factors should be considered when metabolic
parameters are assessed in PDAC. First, respiratory
motion-related artifacts complicate the quantification of
metabolic parameters. It is known that the movement of
the diaphragm during image acquisition (with relatively
long acquisition times, typically 3–4 min per bed pos-
ition) causes motion artifacts, which results in blurring
of anatomical borders, overestimation of lesion volume,
and underestimation of radiotracer uptake in PET/CT-i-
maging [16–18]. Several methods of respiratory-gated im-
aging have been studied, including amplitude-based
optimal respiratory gating (ORG) with HD Chest [18],
resulting in significant decrease in lesion volume and in-
crease in SUVmean values when compared to non-gated
imaging. Results changed more drastically for lesions closer
to the diaphragm. So, evaluation of metabolic behavior of
pancreatic lesions could gain accuracy using ORG.
Secondly, recent literature suggests that specific
genetic mutations affect tumor metabolism [19]. For
example, in colorectal cancer, KRAS-mutated tumors
show increased SUVmax values as compared to KRAS
wild-type tumors [20]. In prostate cancer, AKT1 activa-
tion was associated with accumulation of aerobic gly-
colysis metabolites, whereas MYC overexpression was
associated with dysregulated lipid metabolism [21]. In
parallel, PDAC tumors have a heterogeneous genetic
mutation profile that might affect their metabolic pheno-
type [22–24]. Since intra-tumoral heterogeneity, as visu-
alized and assessed on imaging studies, can play an
important role in defining tumor biology [25], SUVmax
or SUVmean might, intrinsically to their physical defini-
tions, not always be the most relevant parameter.
In this study, we analyzed a large cohort of patients with
proven PDAC scanned with [18F]FDG PET/CT during
diagnostic work-up. To investigate the impact of respiratory
motion correction on the quantification of metabolic pa-
rameters, we analyzed ORG-gated [18F]FDG PET/CT and
the corresponding standard [18F]FDG PET/CT for com-
monly used metabolic parameters, first and second-order
texture features, and their correlation with OS.
Materials and methods
Study design and population
In this retrospective explorative study, data from all pa-
tients who underwent an [18F]FDG PET/CT scan at the
Radboudumc in Nijmegen for suspected pancreatic ma-
lignancy between November 2004 and January 2015
were collected (Table 1). We also included patients who
were scanned elsewhere and were referred for further
diagnostic evaluation. The available histopathological
data acquired by either biopsy or surgery were analyzed
and 158 patients with histologically proven pancreatic
ductal adenocarcinoma were identified (Additional file 1:
Figure S1, CONSORT flowchart). In sixty-nine of these
Table 1 Patient characteristics
Characteristic Number/value
Sex
Male 42
Female 27
Age at PET/CT scan
Mean (± SD) 65.17 ± 8.71
Median (range) 66 (40–82)
Survival after PET/CT scan (weeks)
Mean (± SD) 64.75 ± 63,36
Median (range) 40 (1–253)
Injected dose of 18F-FDG (MBq/kg)
Mean (± SD) 232.99 ± 54.40
Median (range) 231 (81–384)
Resectable tumors 31
Non-resectable tumor 38
Localization tumor
Head 50
Body 15
Tail 4
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patients, an ORG reconstructed scan was available. We
used this group to test the additional value of ORG
scanning on the quantification of metabolic parameters.
Both non-ORG (according to EANM guidelines) and
ORG scans were correlated to OS. Given the retrospect-
ive nature of this study and the anonymized handling of
data, informed consent was waived by the institutional
review board (protocol CMO2018-4420). Scans were
anonymized before review and the readers were unaware
of the clinical or histopathological data.
Image acquisition
All patients fasted for a minimum of 6 h prior to intra-
venous administration of [18F]FDG. Subsequently, pa-
tients rested for approximately 60 min before imaging.
Whole-body PET images were acquired using a Bio-
graph 40 mCT (Siemens Medical Solutions, Knoxville
Tennessee, USA) PET/CT scanner equipped with a
dual-slice CT. PET images were reconstructed according
to the EANM procedure guidelines for tumor PET im-
aging [26]. A TrueX algorithm was used with point
spread function (PSF) and time of flight (TOF) measure-
ments, using three iterations, 21 subsets, matrix size
200 × 200 (pixel spacing of 4.07 mm), full width half
maximum (FWHM) of 3 mm, and using 2 min of PET
data. Post-processing was performed using a 3D
Gaussian filter kernel, 3.0 mm. For respiratory gating, we
used an amplitude-based ORG algorithm, which is inte-
grated in the Syngo 2012A MI.PET/CT software by
Siemens, designated HD Chest. The procedures were
performed as previously described [18]. In short, the
main user input for the ORG algorithm is the percentage
duty cycle, which is the percentage of the total acquired
true coincidences used for image reconstruction. The
ORG algorithm calculates an optimal amplitude range
for a given duty cycle, by calculating the amplitude range
for different values of the lower limit (L). With each
value of L, the upper limit (U) is adjusted to include the
specified percentage of the acquired PET data, and an
amplitude range (W) is calculated through a simple sub-
traction (U − L). The optimal amplitude range is defined
as the smallest amplitude range obtained and calculated
by minimizing W.
The reconstruction settings were kept constant be-
tween ORG and non-ORG images; the percentage of
duty cycles (total acquired true coincidences used for
image reconstruction) was set at 35%, corresponding
with 2min of PET data.
Low-dose CT scans for attenuation corrections were
reconstructed using a B19f convolution kernel, slice
thickness 5.0 mm, and CT images for anatomical refer-
ence were reconstructed using a B31f convolution ker-
nel, slice thickness 3.0 mm.
Image analysis
All [18F]FDG PET/CT scans were evaluated using the
Inveon Research Workspace 4.2 (Preclinical Solutions,
Siemens Medical Solutions USA, Knoxville Tennessee,
USA). After manual annotation of tumor region, a
40% SUVmax isocontour was used to delineate the
metabolic tumor volume. Uptake of [18F]FDG project-
ing over adjacent structures, for example, uptake in
the duodenum or biliary stent, was manually excluded
from the VOIs, unless this was identified as tumor on
contrast-enhanced CT (ceCT) or magnetic resonance
cholangiopancreatography (MRCP). The first and
second-order features were extracted using the PyRa-
diomics toolbox [27]. For the texture feature extrac-
tion, the images were discretized using a fixed
number of 255 bins. The texture features were ex-
tracted from the co-occurrence (GLCM), gray-level
run-length (GLRLM), and gray-level size-zone texture
matrices (GLSZM). These matrices were generated by
considering 26 connected voxels, 13 directions in
three dimensions with a distance of 1 voxel, as de-
scribed previously [27].
Statistical analysis
Statistical analysis was performed using R Software.
Quantification of metabolic parameters measured on
non-ORG versus ORG scans was compared using the
Wilcoxon paired t test (no Gaussian distribution
assumed).
Optimal cutoff values were determined for each indi-
vidual parameter on both ORG and non-ORG scans,
based on Cox proportional hazard model and log-rank
testing in Kaplan Meier survival curves. Overall survival
of a patient was defined from the date of the PET/CT ac-
quisition until the date of the patient’s death.
Univariate analysis of the data was performed on all 69
non-ORG and ORG scans using the Cox proportional
hazard model, after scaling the features using the
standard-scaler of Scikit-learn [28]. Additionally, all
respiratory-gated scans were compared to their corre-
sponding non-ORG counterpart to test the additional
value of respiratory-gating on quantification of metabolic
parameters.
Results
ORG improves the detection of pancreatic lesions and
assessment of intra-tumoral heterogeneity
Pancreatic lesions can present in a wide range of varia-
tions on [18F]FDG PET/CT, but commonly, ductal
adenocarcinomas are FDG avid beyond the level of
liver uptake, with corresponding hypodense lesions on
ceCT. Smaller lesions can be overlooked as physio-
logical [18F]FDG accumulation in the duodenum. Small
size and low absolute level of [18F]FDG accumulation
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renders small lesions particularly prone to partial-volume
effects and motion artifacts. Correction for respiratory
motion artifacts improved the visual detection of small
pancreatic ductal adenocarcinomas in the pancreatic head
and ampullary carcinomas (Fig. 1).
Using ORG reconstruction, the visual assessment of
intra-tumoral regional differences in [18F]FDG accumu-
lation changed, revealing regions of absent [18F]FDG ac-
cumulation or multiple foci of increased [18F]FDG
accumulation (Fig. 2).
Fig. 1 Optimal respiratory gating improves detection of small pancreatic and ampullary lesions. A [18F]FDG PET/CT scan reconstructed according
to EANM guidelines (a, c) and with optimal respiratory gating (b, d), demonstrating markedly improvement of a small ampullary lesion in a 45-
year old male who presented with jaundice. Endoscopic retrograde cholangiopancreatography (ERCP) showed a polyp-like lesion located at the
ampulla of Vater, which was histologically characterized as metaplastic mucosa
Fig. 2 Optimal respiratory gating impacts assessment of intra-tumoral heterogeneity. A [18F]FDG PET/CT scan reconstructed according to EANM
guidelines (a, c) and with optimal respiratory gating (b, d) showing changes in the heterogeneous pattern of intra-tumor [18F]FDG uptake
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ORG significantly impacts quantification of metabolic
parameters
Next, we compared pairs of standard and ORG recon-
structed scans to explore the impact of respiratory mo-
tion on the quantification of metabolic parameters. In
concordance with previous studies using respiratory
gating techniques, the parameters SUVmax, SUVmean,
and SUVdiff showed significantly higher values on ORG
scans compared to the corresponding non-ORG scans.
The other metabolic parameters, e.g., MTV40%, signifi-
cantly decreased (Additional file 2: Table S1, Fig. 3).
First-order features that describe intratumoral hetero-
geneity changed, for example, skewness, kurtosis, stand-
ard deviation, and entropy of the histogram increased
significantly in the ORG reconstructed scan. Except for
the features difference entropy and gray level variance,
second-order features also showed a significant increase
or decrease in the ORG reconstructed scans, for ex-
ample, dissimilarity and joint entropy.
Prognostic impact of metabolic parameters is affected by ORG
As the quantification of metabolic parameters changed
considerably using ORG, we investigated whether their
correlation with OS was consequently affected. For both
standard and ORG reconstructed scans, optimal cutoff
values for correlation with OS were defined. Logistic re-
gression analysis demonstrated that the correlation with
OS of most metabolic parameters changed considerably,
but in an inconsistent pattern (Table 2). Standard
PET-derived parameters SUVmax, SUVmean, and SUVdiff
were no longer associated with OS after ORG recon-
struction (Table 2, Fig. 4), whereas parameters that de-
scribe heterogeneity (sum entropy) became significant,
or borderline significant (difference entropy, joint en-
tropy), associated with OS (Table 2, Fig. 5).
Discussion
Current literature shows equivocal results for the correl-
ation of metabolic parameters measured by [18F]FDG
PET/CT and survival in patients with pancreatic cancer.
In this study, we retrospectively analyzed a cohort of his-
tologically proven PDAC patients to (1) study the impact
of optimal respiratory gating on the quantification of the
most commonly used metabolic parameters and (2) as-
sess whether the correlation of these metabolic parame-
ters and OS is affected.
Fig. 3 Optimal respiratory gating impacts the quantification of [18F]FDG PET-derived image parameters. The quantification of PET-derived
parameters changes significantly after compensating for respiratory motion, as demonstrated for a SUVmax, b SUVmean, c skewness, d Kurtosis,
e difference entropy, and f joint entropy
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In a relatively large cohort of patients, we noted that
ORG results in the improved visibility of especially
smaller sized pancreatic lesions, together with better vis-
ual assessment of intratumoral heterogeneity. Further-
more, we demonstrated that ORG imaging has a
significant impact on quantification of all measured
metabolic parameters, including the commonly used
SUVmax and SUVmean, and also first- and second-order
texture features that describe intratumoral heterogeneity.
As expected, ORG imaging more accurately allocated
measured activity to the corresponding voxel and there-
fore resulted in smaller measured tumor volumes with a
wider range of values. Importantly, the correlation of
metabolic parameters with OS significantly changed
using ORG; some parameters did now correlate whereas
other parameters did no longer correlate with OS.
Table 2 Optimal respiratory gating impacts the correlation of [18F]FDG PET-derived image features with overall survival, assessed by
univariate logistic regression analysis
Image feature Non-ORG ORG
HR 95%CI p value HR 95%CI p value
MTV 1.056 (0.636–1.751) 0.834 1.218 (0.638–2.322) 0.550
SUVmin 1.206 (0.964–1.510) 0.102 0.976 (0.756–1.258) 0.850
SUVmax 1.324 (1.031–1.700) 0.026 1.121 (0.860–1.461) 0.397
SUVmean 1.328 (1.072–1.645) 0.008 1.137 (0.891–1.451) 0.303
SUVdiff 1.360 (1.011–1.830) 0.041 1.155 (0.884–1.510) 0.288
Variance 1.242 (0.965 –1.598) 0.080 1.045 (0.792–1.378) 0.756
Skewness 1.088 (0.843–1.404) 0.516 0.770 (0.577–1.027) 0.076
Kurtosis 0.871 (0.668–1.135) 0.306 0.894 (0.663–1.206) 0.462
Entropy.image 1.232 (0.910–1.669) 0.177 1.198 (0.910–1.577) 0.196
STD 1.271 (0.968–1.669) 0.083 1.064 (0.812–1.395) 0.653
Energy 0.999 (0.769–1.298) 0.992 0.812 (0.594–1.110) 0.181
Contrast 1.051 (0.813–1.359) 0.704 0.809 (0.612–1.069) 0.135
Dissimilarity 1.056 (0.812–1.374) 0.684 0.845 (0.650–1.099) 0.208
Homogeneity.1 0.917 (0.680–1.237) 0.571 1.018 (0.793–1.309) 0.887
Homogeneity.2 0.899 (0.652–1.241) 0.517 0.982 (0.766–1.258) 0.884
Correlation 0.923 (0.724–1.178) 0.521 1.181 (0.899–1.552) 0.231
Difference Entropy.1 1.131 (0.828–1.543) 0.439 1.362 (0.989–1.876) 0.055
Joint Entropy.2 1.093 (0.824–1.450) 0.535 1.290 (0.980–1.698) 0.068
Sum Entropy.3 1.086 (0.819–1.439) 0.568 1.340 (1001–1.795) 0.048
Short.Run.Emphasis 1.097 (0.799–1.506) 0.565 1.040 (0.804–1.346) 0.764
Long.Run.Emphasis 0.914 (0.654–1.278) 0.599 0.923 (0.702–1.214) 0.567
Gray.Level.Non-Uniformity 0.983 (0.590–1.639) 0.948 0.967 (0.503–1.860) 0.919
Gray.Level.Non-Uniformity.Normalized 0.976 (0.746–1.278) 0.861 0.766 (0.552–1.062) 0.101
Run.Length.Non-Uniformity 1.059 (0.650–1.727) 0.817 1.244 (0.670–2.310) 0.489
Run.Length.Non-Uniformity.Normalized 1.094 (0.800–1.496) 0.575 1.033 (0.800–1.334) 0.804
Run.Percentage 1.091 (0.789–1.508) 0.598 1.057 (0.812–1.374) 0.681
GrayLevelVariance 0.971 (0.744–1.268) 0.832 0.873 (0.665–1.145) 0.325
SmallAreaHighGrayLevelEmphasis 1.034 (0.781–1.367) 0.818 1.224 (0.924–1.622) 0.158
GrayLevelNonUniformityNormalized 0.982 (0.752–1.283) 0.895 0.773 (0.559–1.067) 0.110
SizeZoneNonUniformityNormalized 1.082 (0.824–1.420) 0.572 0.876 (0.670–1.145) 0.331
SizeZoneNonUniformity 1.098 (0.740–1.629) 0.643 1.310 (0.796–2.156) 0.286
GrayLevelNonUniformity 1.011 (0.625–1.637) 0.964 1.063 (0.585–1.932) 0.841
LargeAreaEmphasis 0.831 (0.447–1.543) 0.557 0.726 (0.400–1.320) 0.254
ZoneVariance 0.733 (0.262–2.053) 0.555 0.611 (0.240–1.556) 0.198
ZonePercentage 1.078 (0.801–1.451) 0.621 0.963 (0.747–1.241) 0.769
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Recent studies on metabolic parameters and their
predictive value in PDAC have yielded equivocal find-
ings [10, 12, 13, 29], and no single parameter was con-
firmed to predict behavior of PDAC. The uncertainties
in these observations can be addressed from different
angles; first, tumor metabolism is only one feature of a
highly complex tumor microenvironment that involves
a multitude of different functional phenotypes [30].
Other hallmarks of cancer than tumor metabolism per-
haps are more critical to clinical outcome. Secondly,
PDAC are generally characterized by high stromal con-
tent, which impacts pathways of tumor metabolism.
Other metabolic processes, e.g., glutaminolysis or au-
tophagy, are also involved to different degrees [19].
This might in part be reflected by heterogeneous pat-
terns of glucose metabolism and renders a single PET
parameter less relevant in this cancer type. Our study
might help to explain the contradictory results from a
technical standpoint, as it illustrates the difficulties
with accurate quantification of metabolic parameters
in organs just below the diaphragm and subjected to
respiratory motion during acquisition.
The impact of ORG on the prognostic impact of
PET-derived metabolic parameters or clinical decision-
Fig. 4 Optimal respiratory gating impacts the correlation of standard [18F]FDG PET-derived image parameters with overall survival. Kaplan-Meier
survival curves demonstrating the impact of compensation of respiratory motion on the correlation of PET-derived parameters with overall
survival for standard PET-derived parameters, a–b SUVmax, c–d SUVmean, and e–f SUVdiff
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making was beyond the scope of this study and in
general involves more information than the metabolic
parameters investigated here. The retrospective nature
of this study and the cohort size does not allow a com-
prehensive multivariate analysis to investigate whether
ORG-gated measurements result in improved prognostic
impact. Further prospective studies are needed to estab-
lish whether [18F]FDG PET imaging has a prognostic
role and which (set of ) parameters are most accurate.
Furthermore, it is highly interesting to investigate in fur-
ther studies whether, for example, detection of metasta-
ses in liver and lymph nodes or local tumor growth is
impacted by ORG. Moreover, we investigated a homoge-
neous cohort with histologically proven PDAC to rule out
variations by different etiologies, whereas in the clinical
setting, patients with (peri-) ampullary lesions or (focal)
pancreatitis will also be referred for [18F]FDG PET/CT
imaging under the suspicion of pancreatic cancer.
Although correction for respiratory motion impacts
the quantification of metabolic parameters derived from
PET imaging, we could not demonstrate a consistent
pattern in correlation with overall survival. Given the
heterogeneous nature of cancer, it can be hypothesized
that metabolic parameters that assess intratumoral
Fig. 5 Optimal respiratory gating impacts the correlation of [18F]FDG PET-derived texture features with overall survival. Kaplan-Meier survival
curves demonstrating the impact of compensation of respiratory motion on the correlation of PET-derived parameters with overall survival for
PET-derived texture features, a–b sum entropy, c–d joint entropy, and e–f difference entropy
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heterogeneity better classify the underlying tumor biol-
ogy than single-voxel parameters like SUVmax or aver-
aged parameters like SUVmean or TLG. Studies in
esophagus [31], breast [32] and other cancers [33, 34]
support this hypothesis and illustrate the potential of
PET texture features to predict survival and treatment
outcome. However, extracting texture features from PET
images is not standardized and subject to variations in
image reconstruction, tumor delineation, SUV
normalization, and SUV discretization [35–37]. In this
study, we adhered to the 40% SUVmax threshold for
tumor delineation which is widely accepted and recom-
mended by the EANM guidelines [38]. This isocontour
corresponds best with the actual dimensions of the
tumor in non-ORG images. As there is no gold standard
as to assess the actual tumor volume, e.g., CT or MRCP,
and anatomical imaging was not standardized in this co-
hort, our data does not allow cross-validation of this
tumor delineation method for ORG scans.
A recent study in a similar cohort of patients with
PDAC suggests that first-order entropy is an independ-
ent predictor for 2-year survival [14]. As texture features
are increasingly being reported to correlate with gene
expression profiles [39], it is tempting to speculate that
ORG imaging further improves the assessment of intra-
tumoral heterogeneity using advanced image analyses
and facilitates in vivo classification of tumor behavior in
relevant clinical settings [40].
Conclusions
The present study demonstrates that correction for re-
spiratory motion artifacts significantly changes the quanti-
tative measurement of metabolic parameters, including
first- and second-order measures for intratumoral hetero-
geneity, in primary pancreatic ductal adenocarcinoma, with
direct impact on their correlation with overall survival.
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